The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Allergy Vaccine Market Research Report 2025
Synopsis
Allergen Vaccine, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The global Allergy Vaccine market was valued at US$ 1586 million in 2023 and is anticipated to reach US$ 2546.7 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
The market driver for Desensitization Treatment is the increasing prevalence of allergies and the growing need for effective allergy management. Desensitization treatment, also known as immunotherapy, offers a potential cure for allergies by reducing sensitivity to allergens. Rising awareness of the treatment's benefits and advancements in allergy research contribute to market growth. However, challenges include the lengthy treatment duration, potential side effects, and the need for personalized treatment plans. Additionally, reimbursement issues and the availability of alternative allergy management options may pose challenges for market adoption. Despite challenges, the Desensitization Treatment market presents opportunities for improved patient outcomes and better quality of life for individuals with allergies, driving further research and innovation in allergy care.
This report aims to provide a comprehensive presentation of the global market for Allergy Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Vaccine.
Report Scope
The Allergy Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergy Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
WOLW Pharma
HAL
Holister Stier
Leti
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Allergy Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Allergy Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Allergen Vaccine, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The global Allergy Vaccine market was valued at US$ 1586 million in 2023 and is anticipated to reach US$ 2546.7 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
The market driver for Desensitization Treatment is the increasing prevalence of allergies and the growing need for effective allergy management. Desensitization treatment, also known as immunotherapy, offers a potential cure for allergies by reducing sensitivity to allergens. Rising awareness of the treatment's benefits and advancements in allergy research contribute to market growth. However, challenges include the lengthy treatment duration, potential side effects, and the need for personalized treatment plans. Additionally, reimbursement issues and the availability of alternative allergy management options may pose challenges for market adoption. Despite challenges, the Desensitization Treatment market presents opportunities for improved patient outcomes and better quality of life for individuals with allergies, driving further research and innovation in allergy care.
This report aims to provide a comprehensive presentation of the global market for Allergy Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Vaccine.
Report Scope
The Allergy Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergy Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
WOLW Pharma
HAL
Holister Stier
Leti
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Allergy Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Allergy Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Allergy Vaccine Market Overview
1.1 Product Overview and Scope of Allergy Vaccine
1.2 Allergy Vaccine Segment by Type
1.2.1 Global Allergy Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Allergy Vaccine Segment by Application
1.3.1 Global Allergy Vaccine Market Value by Application: (2024-2030)
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Global Allergy Vaccine Market Size Estimates and Forecasts
1.4.1 Global Allergy Vaccine Revenue 2019-2030
1.4.2 Global Allergy Vaccine Sales 2019-2030
1.4.3 Global Allergy Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Allergy Vaccine Market Competition by Manufacturers
2.1 Global Allergy Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Allergy Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Allergy Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Allergy Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Allergy Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Allergy Vaccine, Product Type & Application
2.7 Allergy Vaccine Market Competitive Situation and Trends
2.7.1 Allergy Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Allergy Vaccine Players Market Share by Revenue
2.7.3 Global Allergy Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Allergy Vaccine Retrospective Market Scenario by Region
3.1 Global Allergy Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Allergy Vaccine Global Allergy Vaccine Sales by Region: 2019-2030
3.2.1 Global Allergy Vaccine Sales by Region: 2019-2024
3.2.2 Global Allergy Vaccine Sales by Region: 2025-2030
3.3 Global Allergy Vaccine Global Allergy Vaccine Revenue by Region: 2019-2030
3.3.1 Global Allergy Vaccine Revenue by Region: 2019-2024
3.3.2 Global Allergy Vaccine Revenue by Region: 2025-2030
3.4 North America Allergy Vaccine Market Facts & Figures by Country
3.4.1 North America Allergy Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Allergy Vaccine Sales by Country (2019-2030)
3.4.3 North America Allergy Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Allergy Vaccine Market Facts & Figures by Country
3.5.1 Europe Allergy Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Allergy Vaccine Sales by Country (2019-2030)
3.5.3 Europe Allergy Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Allergy Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Allergy Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Allergy Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Allergy Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Allergy Vaccine Market Facts & Figures by Country
3.7.1 Latin America Allergy Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Allergy Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Allergy Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Allergy Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Allergy Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Allergy Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Allergy Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Allergy Vaccine Sales by Type (2019-2030)
4.1.1 Global Allergy Vaccine Sales by Type (2019-2024)
4.1.2 Global Allergy Vaccine Sales by Type (2025-2030)
4.1.3 Global Allergy Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Allergy Vaccine Revenue by Type (2019-2030)
4.2.1 Global Allergy Vaccine Revenue by Type (2019-2024)
4.2.2 Global Allergy Vaccine Revenue by Type (2025-2030)
4.2.3 Global Allergy Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Allergy Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Allergy Vaccine Sales by Application (2019-2030)
5.1.1 Global Allergy Vaccine Sales by Application (2019-2024)
5.1.2 Global Allergy Vaccine Sales by Application (2025-2030)
5.1.3 Global Allergy Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Allergy Vaccine Revenue by Application (2019-2030)
5.2.1 Global Allergy Vaccine Revenue by Application (2019-2024)
5.2.2 Global Allergy Vaccine Revenue by Application (2025-2030)
5.2.3 Global Allergy Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Allergy Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ALK-Abello
6.1.1 ALK-Abello Corporation Information
6.1.2 ALK-Abello Description and Business Overview
6.1.3 ALK-Abello Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ALK-Abello Allergy Vaccine Product Portfolio
6.1.5 ALK-Abello Recent Developments/Updates
6.2 Stallergenes Greer
6.2.1 Stallergenes Greer Corporation Information
6.2.2 Stallergenes Greer Description and Business Overview
6.2.3 Stallergenes Greer Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Stallergenes Greer Allergy Vaccine Product Portfolio
6.2.5 Stallergenes Greer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Allergy Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Allergy Therapeutics
6.4.1 Allergy Therapeutics Corporation Information
6.4.2 Allergy Therapeutics Description and Business Overview
6.4.3 Allergy Therapeutics Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergy Therapeutics Allergy Vaccine Product Portfolio
6.4.5 Allergy Therapeutics Recent Developments/Updates
6.5 WOLW Pharma
6.5.1 WOLW Pharma Corporation Information
6.5.2 WOLW Pharma Description and Business Overview
6.5.3 WOLW Pharma Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 WOLW Pharma Allergy Vaccine Product Portfolio
6.5.5 WOLW Pharma Recent Developments/Updates
6.6 HAL
6.6.1 HAL Corporation Information
6.6.2 HAL Description and Business Overview
6.6.3 HAL Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HAL Allergy Vaccine Product Portfolio
6.6.5 HAL Recent Developments/Updates
6.7 Holister Stier
6.6.1 Holister Stier Corporation Information
6.6.2 Holister Stier Description and Business Overview
6.6.3 Holister Stier Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Holister Stier Allergy Vaccine Product Portfolio
6.7.5 Holister Stier Recent Developments/Updates
6.8 Leti
6.8.1 Leti Corporation Information
6.8.2 Leti Description and Business Overview
6.8.3 Leti Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Leti Allergy Vaccine Product Portfolio
6.8.5 Leti Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Allergy Vaccine Industry Chain Analysis
7.2 Allergy Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Allergy Vaccine Production Mode & Process
7.4 Allergy Vaccine Sales and Marketing
7.4.1 Allergy Vaccine Sales Channels
7.4.2 Allergy Vaccine Distributors
7.5 Allergy Vaccine Customers
8 Allergy Vaccine Market Dynamics
8.1 Allergy Vaccine Industry Trends
8.2 Allergy Vaccine Market Drivers
8.3 Allergy Vaccine Market Challenges
8.4 Allergy Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Allergy Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Allergy Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Allergy Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Allergy Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Allergy Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Allergy Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Allergy Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Allergy Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Allergy Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Allergy Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Allergy Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Allergy Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Allergy Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Allergy Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Allergy Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Allergy Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Allergy Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Allergy Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Allergy Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Allergy Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Allergy Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Allergy Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Allergy Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Allergy Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Allergy Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Allergy Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Allergy Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Allergy Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Allergy Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Allergy Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Allergy Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Allergy Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Allergy Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Allergy Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Allergy Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Allergy Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Allergy Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Allergy Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Allergy Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Allergy Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Allergy Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Allergy Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Allergy Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Allergy Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Allergy Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Allergy Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Allergy Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Allergy Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Allergy Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Allergy Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Allergy Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Allergy Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Allergy Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Allergy Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Allergy Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Allergy Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Allergy Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Allergy Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Allergy Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Allergy Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Allergy Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Allergy Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Allergy Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Allergy Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Allergy Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Allergy Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Allergy Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. ALK-Abello Corporation Information
Table 71. ALK-Abello Description and Business Overview
Table 72. ALK-Abello Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. ALK-Abello Allergy Vaccine Product
Table 74. ALK-Abello Recent Developments/Updates
Table 75. Stallergenes Greer Corporation Information
Table 76. Stallergenes Greer Description and Business Overview
Table 77. Stallergenes Greer Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Stallergenes Greer Allergy Vaccine Product
Table 79. Stallergenes Greer Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Allergy Vaccine Product
Table 84. Merck Recent Developments/Updates
Table 85. Allergy Therapeutics Corporation Information
Table 86. Allergy Therapeutics Description and Business Overview
Table 87. Allergy Therapeutics Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Allergy Therapeutics Allergy Vaccine Product
Table 89. Allergy Therapeutics Recent Developments/Updates
Table 90. WOLW Pharma Corporation Information
Table 91. WOLW Pharma Description and Business Overview
Table 92. WOLW Pharma Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. WOLW Pharma Allergy Vaccine Product
Table 94. WOLW Pharma Recent Developments/Updates
Table 95. HAL Corporation Information
Table 96. HAL Description and Business Overview
Table 97. HAL Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. HAL Allergy Vaccine Product
Table 99. HAL Recent Developments/Updates
Table 100. Holister Stier Corporation Information
Table 101. Holister Stier Description and Business Overview
Table 102. Holister Stier Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Holister Stier Allergy Vaccine Product
Table 104. Holister Stier Recent Developments/Updates
Table 105. Leti Corporation Information
Table 106. Leti Description and Business Overview
Table 107. Leti Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Leti Allergy Vaccine Product
Table 109. Leti Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Allergy Vaccine Distributors List
Table 113. Allergy Vaccine Customers List
Table 114. Allergy Vaccine Market Trends
Table 115. Allergy Vaccine Market Drivers
Table 116. Allergy Vaccine Market Challenges
Table 117. Allergy Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Allergy Vaccine
Figure 2. Global Allergy Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Allergy Vaccine Market Share by Type in 2023 & 2030
Figure 4. Subcutaneous Immunotherapy Product Picture
Figure 5. Sublingual Immunotherapy Product Picture
Figure 6. Global Allergy Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Allergy Vaccine Market Share by Application in 2023 & 2030
Figure 8. Allergic Rhinitis
Figure 9. Allergic Asthma
Figure 10. Other
Figure 11. Global Allergy Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Allergy Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Allergy Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global Allergy Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 15. Allergy Vaccine Report Years Considered
Figure 16. Allergy Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Allergy Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Allergy Vaccine Players: Market Share by Revenue in 2023
Figure 19. Allergy Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Allergy Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Allergy Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Allergy Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Allergy Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Allergy Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Allergy Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Allergy Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Allergy Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Allergy Vaccine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Allergy Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Allergy Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Allergy Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Allergy Vaccine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Allergy Vaccine by Type (2019-2030)
Figure 55. Global Allergy Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Allergy Vaccine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Allergy Vaccine by Application (2019-2030)
Figure 58. Global Allergy Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 59. Allergy Vaccine Value Chain
Figure 60. Allergy Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
